Puma Biotechnology Stock Investor Sentiment
| PBYI Stock | USD 6.42 0.44 6.41% |
Under 55% of Puma Biotechnology's investor base is interested to short. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that many traders are impartial. Puma Biotechnology's investing sentiment shows overall attitude of investors towards Puma Biotechnology.
Comfort Level 45
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Puma Biotechnology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Puma Biotechnology.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Puma Historical Sentiment
Although Puma Biotechnology's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Puma, such as negative comments on social media and news outlets, may cause fear in the market and push Puma Biotechnology's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Puma.
Puma Biotechnology Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Puma Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Puma Biotechnology Historical Investor Sentiment
Investor biases related to Puma Biotechnology's public news can be used to forecast risks associated with an investment in Puma. The trend in average sentiment can be used to explain how an investor holding Puma can time the market purely based on public headlines and social activities around Puma Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Puma Biotechnology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Puma Biotechnology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Puma Biotechnology news discussions. The higher the estimate score, the more favorable the investor's outlook on Puma Biotechnology.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Puma Biotechnology's Stock prices. Below is the latest headlines and news related to Puma Biotechnology Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Puma Biotechnology that are available to investors today. This information is accessible both publicly - through Puma Biotechnology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Puma-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Puma Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Puma Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Puma Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Puma Biotechnology alpha.
Puma Largest EPS Surprises
Earnings surprises can significantly impact Puma Biotechnology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-08-07 | 2025-06-30 | 0.09 | 0.12 | 0.03 | 33 | ||
2024-08-01 | 2024-06-30 | -0.13 | -0.09 | 0.04 | 30 | ||
2024-02-29 | 2023-12-31 | 0.3 | 0.26 | -0.04 | 13 | ||
2023-11-02 | 2023-09-30 | 0.08 | 0.12 | 0.04 | 50 | ||
2023-08-03 | 2023-06-30 | 0.01 | 0.05 | 0.04 | 400 | ||
2022-11-03 | 2022-09-30 | -0.05 | -0.01 | 0.04 | 80 |
There is far too much social signal, news, headlines, and media speculation about Puma Biotechnology that are available to investors today. This information is accessible both publicly - through Puma Biotechnology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Puma-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Puma Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Puma Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Puma Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Puma Biotechnology alpha.
Puma Biotechnology Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | 12 Health Care Stocks Moving In Mondays Intraday Session | 11/10/2025 |
2 | Disposition of 20000 shares by Miller Michael Patrick of Puma Biotechnology at 4.8614 subject to Rule 16b-3 | 11/11/2025 |
3 | December 2025s Promising Penny Stocks To Consider | 12/03/2025 |
4 | Why analysts upgrade Puma Biotechnology Inc stock - 2025 Winners Losers Consistent Income Trade Ideas - moha.gov.vn | 12/16/2025 |
5 | How Puma Biotechnology Inc. stock reacts to oil prices - Weekly Risk Report AI Driven Stock Reports - | 12/19/2025 |
6 | Puma Biotechnology Added to the NASDAQ Biotechnology Index | 12/22/2025 |
7 | Puma Biotechnology Stock Jump Looks Great, But How Secure Is That Gain - Trefis | 01/02/2026 |
8 | Disposition of 4540 shares by Maximo Nougues of Puma Biotechnology at 5.844 subject to Rule 16b-3 | 01/06/2026 |
9 | Will Puma Biotechnology Inc. stock keep outperforming rivals - Weekly Trade Recap High Accuracy Swing Trade Signals - ulpravda.ru | 01/08/2026 |
10 | EPS Watch How Puma Biotechnology Inc stock valuations compare to rivals - Weekly Stock Analysis High Accuracy Trade Signal Alerts - moha.gov.vn | 01/13/2026 |
11 | New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand | 01/22/2026 |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |